BAY-1895344

CAS: 1876467-74-1

Ref. 3D-BB178556

Produktinformation

• Name: BAY-1895344

Beschreibung

BAY-1895344 is an inhibitor of the CDK4 and CDK6 proteins, which are tumor-promoting enzymes that regulate cell cycle progression. BAY-1895344 has been evaluated in clinical studies for the treatment of cancer with promising results. This drug was also shown to increase epidermal growth factor (EGF) levels in vitro and to promote autophagy, a process whereby cells degrade their own components. In addition, this compound has been shown to have a positive effect on telomere length and tumor response in patients with squamous carcinoma.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 375.43 g/mol
• Formel: C₂₀H₂₁N₇O
• Reinheit: Min. 95%